Coagulation Sciences

What Coagulation Sciences does

Coagulation Sciences LLC is a privately held, early-stage medical device company founded by Dr. Sheldon Goldstein, an Internist and Cardiac Anesthesiologist, and headquartered in Riverdale, New York. The company develops the Multiple Coagulation Test System (MCTS), a desktop point-of-care diagnostic device that automatically performs 12–18 blood tests simultaneously to compare the efficacy of up to 5–8 blood and coagulation therapies, delivering actionable results in approximately 10 minutes at the patient's bedside. The device uses a single-use disposable Blood Testing Cartridge and is positioned to enable personalized transfusion decisions in place of one-size-fits-all protocols, with an initial intended use in cardiac surgery and planned expansion to other surgeries associated with major bleeding.

The company serves hospitals (operating rooms and emergency departments), medical laboratories, scientific research institutions, and, in a positioning-only capacity, individual patients concerned about unnecessary transfusions. Its stated value proposition centers on reducing unnecessary blood transfusions (claimed at 40% or more), arresting bleeding more rapidly, improving patient safety, and lowering operating-room and blood-bank costs. The MCTS is described as the first and only point-of-care device performing multiple simultaneous coagulation tests that compares multiple therapies.

The intended business model is enterprise field sales of the MCTS hardware directly to hospitals and laboratories, combined with recurring, usage-based revenue from the disposable Blood Testing Cartridges required for each test—a classic razor/razorblade model. Pricing is not publicly disclosed. Go-to-market involves direct engagement with hospital administrators, blood bank directors, and clinical staff. The company is very small (1–10 employees), remains pre-commercial as an FDA-regulated device, and lists no named customers, partnerships, or awards in the available data.

Name

Coagulation Sciences

Legal name

Coagulation Sciences LLC

Website

https://coagulationsciences.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Coagulation Sciences is an early-stage medical device company developing the Multiple Coagulation Test System (MCTS), a point-of-care device that runs simultaneous blood-clotting tests to guide personalized transfusion decisions for hospitals, laboratories, and researchers.

Ownership category

akta.pro rank

Product category

Point-of-Care Coagulation Diagnostics

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAHAOAC

Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

SECONDARYHLAHAAAB

Hematology & Coagulation Diagnostics

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAHAAAH

Blood Bank, Transfusion Medicine & Immunohematology

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

• Point-of-care diagnostics
• Coagulation testing devices
• Blood coagulation analysis
• Transfusion management systems
• Medical diagnostic equipment

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. MCTS Medical Device Sales: Sale of the Multiple Coagulation Test System desktop device and associated single-use disposable Blood Testing Cartridges to hospitals and medical laboratories.
2. Blood Testing Consumables: Recurring revenue from single-use disposable Blood Testing Cartridges required for each test performed on the MCTS system.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Coagulation Sciences develops and manufactures the Multiple Coagulation Test System (MCTS™), a desktop point-of-care medical device that automatically performs 12-18 blood tests simultaneously comparing up to 8 coagulation therapies. The system uses single-use disposable Blood Testing Cartridges and delivers actionable results in approximately 10 minutes at the patient's bedside, enabling personalized, evidence-based transfusion decisions during cardiac surgery, trauma care, and other high-bleeding procedures.

Product overview

Coagulation Sciences offers a single unified product—the Multiple Coagulation Test System (MCTS™)—a desktop point-of-care diagnostic device designed for rapid blood coagulation analysis during critical medical procedures. The MCTS performs multiple blood tests simultaneously to compare the efficacy of different treatment options, helping physicians make evidence-based, personalized transfusion decisions. The system uses single-use disposable Blood Testing Cartridges and delivers results in approximately 10 minutes at the patient's bedside.

Differentiator

Problem solved

Functional benefit

Brands

• MCTS™: Multiple Coagulation Test System - A desktop medical device that performs rapid point-of-care blood clotting analysis during critical procedures, comparing the efficacy of multiple treatments.

Products and services

• Multiple Coagulation Test System (MCTS™)

Quantifiable outcome

• At least 40% reduction in unnecessary blood transfusions
• +2 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Haemonetics: Haemonetics is the leader in point-of-care hemostasis management via its TEG (thromboelastography) systems, which guide transfusion decisions in cardiac and major surgeries — directly competing with MCTS in the same clinical workflow and customer base.
• Stago: Stago specializes in laboratory coagulation diagnostics (STA-R Max, STA Compact) and is a recognized reference for hemostasis testing; it competes with MCTS in guiding transfusion decisions, especially in hospital labs that perform STAT coagulation work.
• Werfen: Werfen markets ROTEM and ROTEM sigma point-of-care viscoelastic coagulation analyzers used in ORs and ICUs to guide transfusion therapy, overlapping directly with MCTS's use case in cardiac surgery and trauma.
• Helena Laboratories: Helena Laboratories manufactures point-of-care hemostasis devices (e.g., Cascade Abrazo) used for rapid coagulation assessment in surgical and critical care settings, competing with MCTS for the bedside coagulation-testing niche.
• HemoSonics (a Haemonetics company): HemoSonics' Quantra QPlus system is a cartridge-based point-of-care viscoelastic coagulation analyzer used in surgical and critical care settings to inform transfusion decisions — closely analogous to MCTS's POC cartridge architecture.

Broad incumbents

• Sysmex: Sysmex's CS-series (e.g., CS-2500, CS-5100) automated coagulation analyzers are widely used in hospital labs for routine and specialized hemostasis testing, providing an alternative to MCTS's bedside approach for guiding transfusion therapy.
• Siemens Healthineers: Siemens Healthineers (now including the former Siemens Healthineers Diagnostics) offers INNOVANCE coagulation reagents and BCS/Atellica analyzers used in hospital hemostasis labs, overlapping with MCTS in transfusion decision support.
• Abbott: Abbott's i-STAT system with coagulation cartridges (ACT, PT/INR) is a widely deployed point-of-care diagnostic platform in ORs and ERs, competing for the same bedside coagulation testing workflow with a far larger installed base.
• Roche Diagnostics: Roche offers a broad portfolio of central-lab coagulation analyzers and reagents (cobas t series), serving the same hospital transfusion management workflow as MCTS but from the centralized lab rather than the bedside.

Emerging players

• Entegrion: Entegrion develops point-of-care hemostasis and transfusion management diagnostics, addressing the same gap between central-lab coagulation tests and bedside transfusion decisions that MCTS targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/coagulation-sciences-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coagulation Sciences